MOSCOW — Russia’s health officials have given a go-ahead to testing a combination of the AstraZeneca coronavirus shot and the single-dose version of the domestically developed Sputnik V vaccine, according to the country’s registry of approved clinical trials.
Coronavirus
Associated Press: Russia OKs testing combination of Sputnik, AstraZeneca shots
A medical worker holds vials of COVID-19 vaccines produced by (from L) Oxford-AstraZeneca (India's Covishield), Pfizer Inc. and BioNTech SE, Sputnik V and Sinopharm Group Co. at the Belgrade fair vaccination center in Belgrade, Serbia, on March 21, 2021.
